Shipments of J&J COVID-19 vaccines halted as FDA probes error that ruined 15M doses

Listen

Shipments of Johnson & Johnson's COVID-19 vaccines to the federal government will be halted while the FDA investigates an error at an Emergent BioSolutions manufacturing plant in Baltimore that ruined about 15 million vaccine doses, The New York Times reported March 31. 

Workers at the plant accidentally conflated the ingredients of Johnson & Johnson's COVID-19 vaccine several weeks ago, ruining about 15 million doses. The mistake, which federal officials said was a human error, forced regulators to delay authorization of the plant's production lines, according to the Times

Emergent BioSolutions has contracted with both Johnson & Johnson and AstraZeneca to help produce their COVID-19 vaccines. 

The error doesn't affect the Johnson & Johnson vaccines now being distributed throughout the U.S., the Times reported. Those doses were made in the Netherlands. 

But all future shipments of the Johnson & Johnson vaccine were supposed to come from the Emergent plant in Baltimore. 

Federal officials told the Times they still expect to have enough doses of COVID-19 vaccines to fulfill President Joe Biden's promise to vaccinate every adult by the end of May. 

Read the full article here

More articles on pharmacy:
California sheriff's office ignored warning, implied man's death was linked to COVID-19 vaccine
Pfizer, BioNTech to test version of their COVID-19 vaccine that doesn't need ultracold storage
8 key first-time generic drugs the FDA approved in 2020

 

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Whitepapers

Featured Webinars